Discontinuation report DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP
Report ID | 1262 |
Drug Identification Number | 00619698 |
Brand name | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP |
Common or Proper name | Dopamine |
Company Name | HOSPIRA HEALTHCARE ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DOPAMINE HYDROCHLORIDE DEXTROSE |
Strength(s) | 1.6MG 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 400 mg/250 mL |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-02-27 |
Remaining supply date | 2017-02-27 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Expiry date is June 1st, 2017 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / Service à la clientele 1-866-488-6088 option 3 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-11-26 | French | Compare |
v5 | 2018-11-26 | English | Compare |
v4 | 2018-11-26 | French | Compare |
v3 | 2018-11-26 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 6 of 6